Compliance updated on Jun 19, 2026 Screened by AAOIFI-Certified Shariah Advisor & Auditor

Financial data updated nightly

BSF Enterprise PLC

BSFA.L ✓ COMPLIANT ☆ Track — members

LSE · Healthcare · Pharmaceuticals ·

UK Micro Cap Analyst: N/A

Last Close

$0.02

▲ +2.22%

Market Cap $3.00M · Vol 1.42M

Key Metrics

P/E Ratio

N/A

FWD: N/A

Market Cap

$3.00M

Micro Cap

Div Yield

N/A

Semi-annual dividend

EPS Growth

N/A

YoY

RSI (14)

64.23

Momentum

Beta

3.38

vs Market

52W High

$0.05

70.75% below

52W Low

$0.01

135.36% above

Volume

1.42M

Avg 3.15M

P/B

1.54

Price-to-book

ROE

N/A

Return on equity

Free Float

80.32%

Public shares

Shariah Compliance8 STANDARDS

✓ Yes, BSF Enterprise PLC (BSFA.L) stock is Shariah compliant

AAOIFI—
Dow Jones Islamic (DJIM)—
FTSE Shariah—
MSCI Islamic—
S&P Shariah—
Al Rajhi—
Alinma—
Albilad—

Unlock the full Shariah report

See the verdict under each standard, the exact screening ratios, purification and zakat per share. AAOIFI-certified methodology trusted by global Islamic funds.

Which standards does BSFA.L pass?

The full report shows the verdict under each of the 8 major Shariah standards, with the business-activity and financial-ratio screens behind every one.

Do I need to purify my investment?

Members see the purification amount per share, updated every financial period under the AAOIFI methodology.

Can I calculate zakat for my shares?

Members get zakat per share and a built-in calculator for their exact holding.

Historical Returns

+4.55%

+31.43%

-29.23%

-36.11%

YTD

-39.47%

-43.21%

-90.76%

-79.09%

Financials & Valuation

TTM · Annual

Total Revenue	$71.02K
Net Income	$-1,496,700.00
Revenue Growth (YoY)	-8.63%
Gross Margin	-241.25%
Operating Margin	-2,299.56%
Net Profit Margin	-2,107.36%
ROE	N/A
ROA · ROIC	-37.43% · N/A

P/E Ratio	N/A
Forward P/E (FY1)	N/A
PEG Ratio	N/A
P/S	75.11
P/B	1.54
P/FCF	N/A
EPS Growth	N/A
Outstanding Shares	193.75M

Technical Indicators

50-Day SMA	$0.01
200-Day SMA	$0.02
RSI (14)	64.23
Beta	3.38
52-Week High	$0.05
52-Week Low	$0.01

Volume Today	1.42M
Avg Daily Volume (30D)	3.15M
Relative Volume	0.45x
Volatility (10D)	235.31
Volatility (30D)	169.55
Free Float	80.32%

Analyst Consensus

N/A

Current Price $0.02

Mean Target N/A

52W Low$0.01 52W High$0.05

Current

Target

$0.01 $0.05

Current Analyst target

· 0 analysts

Identifiers

ExchangeLSE

FIGIBBG00PV1PJB6

ISINGB00BHNBDQ51

CountryUnited Kingdom

Sub-IndustryBiopharmaceuticals

Earnings DateN/A

TypeStocks

Instrument TypeORD Ordinary Share

Similar Halal Stocks

REGN Regeneron Pharmaceuticals Inc -0.31% 207940.KS Samsung Biologics Co Ltd -1.02% UCB.BR Ucb SA -3.10% CSL.AX CSL Ltd -0.74% BIIB Biogen Inc -0.39%

Company Profile

BSF Enterprise PLC is a United Kingdom-based biotech company. The Company develops and commercializes cell-based tissue engineered solutions, including lab-grown leather, cultivated meat, and corneal repair technologies. The principal activity of the Company is to undertake the acquisition of businesses in the biotechnology, marketing and e-commerce sectors. The Company operates through its wholly owned subsidiaries, 3D Bio-Tissues Limited (3DBT), Lab Grown Leather Limited (LGL), Kerato Limited (Kerato), and BSF Enterprise (Hong Kong) Limited (BSF HK). 3DBT is a tissue engineering company developing processes and tools for others to create functional tissues from a range of cell types. This includes a platform for generating structured tissues as well as media supplements that can accelerate and increase cell performance. Kerato utilizes multi-patented technology with expertise in tissue engineering and biomaterials to develop bio-equivalent corneal tissue.